Allurion Technologies Inc. - SIC # 8040 -

Ticker Exchange SIC # Website Latest Ticker
ALUR New York 8040 www.allurion.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Allurion Technologies Inc.

Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS - Jun 17th, 2025 6:00 am
Allurion to Present at Jefferies Global Healthcare Conference - May 29th, 2025 2:05 pm
Allurion Technologies Inc. (ALUR) Returns to France with 12.2% Weight Loss, 6.6% Muscle Gain Results - May 27th, 2025 5:51 pm
Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program - May 27th, 2025 2:05 pm
Allurion Technologies Inc (ALUR) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - May 15th, 2025 1:12 am
Allurion Reports First Quarter 2025 Financial Results and Provides Business Update - May 14th, 2025 6:00 am
Allurion Presents Data on the Allurion Balloon and AI-Powered Virtual Care Suite with and without GLP-1s to Optimize Muscle Mass and Increase Weight Loss - May 13th, 2025 2:05 pm
Allurion to Report First Quarter 2025 Financial Results on May 14, 2025 - May 5th, 2025 2:05 pm
Allurion Announces Postponement of Special Meeting of Stockholders - Apr 3rd, 2025 2:30 pm
Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - Mar 26th, 2025 6:00 am
Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence - Mar 20th, 2025 2:05 pm
Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025 - Mar 12th, 2025 2:05 pm
Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity - Mar 4th, 2025 2:05 pm
Allurion to Participate in Upcoming Investor Conferences - Feb 25th, 2025 2:05 pm
Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline - Feb 20th, 2025 2:05 pm
Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline - Feb 19th, 2025 7:03 am
Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity - Feb 18th, 2025 6:30 am
Allurion Relaunches in France - Feb 13th, 2025 6:30 am
How Much Upside is Left in Allurion Technologies, Inc. (ALUR)? Wall Street Analysts Think 374.67% - Feb 10th, 2025 7:55 am
Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk - Jan 24th, 2025 2:15 pm